• Oncoclinicas agreed to sell its entire stake in Saudi oncology joint venture Specialized Medical Treatment Company to Al Faisaliah Group, Advanced Drug.
• Transaction value about USD 6.55 million; cash payment due at closing.
• Deal supports portfolio simplification, deleveraging, refocus on Brazil operations; removes future SMTC funding commitments, operational, FX risk.
• Closing conditional on definitive documents, customary conditions, Saudi regulatory approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on July 22, 2026, and is solely responsible for the information contained therein.